TY - JOUR
T1 - Recovery of live virus after storage at ambient temperature using ViveST™
AU - Barr, Kelli L.
AU - Messenger, Ali M.
AU - Anderson, Benjamin D.
AU - Friary, John A.
AU - Heil, Gary L.
AU - Reece, Kristy
AU - Gray, Gregory C.
N1 - Funding Information:
This work was supported by grants from the US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program ( I0179_10_UN Dr. Gray) and from the National Institute of Allergy and Infectious Diseases ( R01 AI068803 – Dr. Gray).
PY - 2013/1
Y1 - 2013/1
N2 - Background: A major impediment to performing virological field studies in developing nations is the lack of ultra-low freezers as well as the expense and difficulty of shipping frozen samples. A commercially available product, ViveST™, was developed to preserve nucleic acids at ambient temperature for use in specimen storage and transportation. However, its applications as a viral storage, transport and recovery device have not been evaluated. Objective: To examine the ability of ViveST to preserve live virus following storage at ambient temperature. Study design: A panel of six viruses was stored at ambient temperature (∼22. °C) in ViveST with fetal bovine serum (FBS), or ViveST with minimal essential media (MEM) and compared with virus stored in universal transport media (M4RT), MEM, and FBS alone. Stored viruses included: human adenovirus (14p), dengue virus 2 (16608), echovirus 3 (Morrisey), human rhinovirus 15 (1734), Coxsackie virus B5 (Faulkner), and herpes simplex virus 1 (HF). After 7 days storage at ambient temperature, virus recovery was measured via titration using viral plaque assays or focus-forming unit assays. Results: Viral titer studies indicate that ViveST with either FBS or M4RT preserved/recovered 5 different viruses for 1 week at ambient temperature. MEM preserved 4 viruses while FBS and ViveST with MEM preserved 3 viruses each. Statistical analyses indicate that M4RT and ViveST with FBS preserved significantly more virus than the other treatments. Conclusions: These data suggest that ViveST with either FBS or M4RT may be useful in field specimen collection scenarios where ultra-cold storage is not available.
AB - Background: A major impediment to performing virological field studies in developing nations is the lack of ultra-low freezers as well as the expense and difficulty of shipping frozen samples. A commercially available product, ViveST™, was developed to preserve nucleic acids at ambient temperature for use in specimen storage and transportation. However, its applications as a viral storage, transport and recovery device have not been evaluated. Objective: To examine the ability of ViveST to preserve live virus following storage at ambient temperature. Study design: A panel of six viruses was stored at ambient temperature (∼22. °C) in ViveST with fetal bovine serum (FBS), or ViveST with minimal essential media (MEM) and compared with virus stored in universal transport media (M4RT), MEM, and FBS alone. Stored viruses included: human adenovirus (14p), dengue virus 2 (16608), echovirus 3 (Morrisey), human rhinovirus 15 (1734), Coxsackie virus B5 (Faulkner), and herpes simplex virus 1 (HF). After 7 days storage at ambient temperature, virus recovery was measured via titration using viral plaque assays or focus-forming unit assays. Results: Viral titer studies indicate that ViveST with either FBS or M4RT preserved/recovered 5 different viruses for 1 week at ambient temperature. MEM preserved 4 viruses while FBS and ViveST with MEM preserved 3 viruses each. Statistical analyses indicate that M4RT and ViveST with FBS preserved significantly more virus than the other treatments. Conclusions: These data suggest that ViveST with either FBS or M4RT may be useful in field specimen collection scenarios where ultra-cold storage is not available.
KW - Preservation
KW - Recovery
KW - Storage
KW - Transport
KW - Virus
UR - http://www.scopus.com/inward/record.url?scp=84871478230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871478230&partnerID=8YFLogxK
U2 - 10.1016/j.jcv.2012.09.005
DO - 10.1016/j.jcv.2012.09.005
M3 - Article
C2 - 23046621
AN - SCOPUS:84871478230
SN - 1386-6532
VL - 56
SP - 57
EP - 61
JO - Journal of Clinical Virology
JF - Journal of Clinical Virology
IS - 1
ER -